MBMusa Bin Bashir

Musa Bin Bashir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Musa Bin Bashir has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Contemporary cardiometabolic and inflammation targeting therapies reduce residual cardiovascular risk in an endpoint harmonized meta analysis

    by Musa Bin Bashir, Chen Chen, Azhgool Mohammad, Rzgar Mustafa Ahmed, Zhiquan Wang

    Residual cardiovascular risk remains substantial despite contemporary preventive therapy. Multiple pharmacological strategies targeting metabolic, lipid-related, cardiorenal, and inflammatory pathways have shown cardiovascular benefit in randomized trials, but differences in endpoint definitions and composite outcome structures complicate cross-trial interpretation. We aimed to evaluate whether contemporary cardiometabolic and anti-inflammatory therapies are associated with lower major adverse cardiovascular event risk using an endpoint-harmonized framework. We conducted a systematic review and meta-analysis of randomized controlled trials evaluating sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, proprotein convertase subtilisin/kexin type 9 inhibitors, omega-3 fatty acid-based therapies, and anti-inflammatory agents. Databases were searched from inception through February 2026. The primary outcome was endpoint-harmonized major adverse cardiovascular events (MACE), defined as the trial-reported cardiovascular composite endpoint judged most comparable across studies according to prespecified harmonization rules. A prespecified sensitivity analysis was restricted to strict 3-point MACE, defined as cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. Hazard ratios (HRs) were pooled on the log scale using random-effects models with restricted maximum likelihood estimation and Hartung–Knapp adjustment. Seventeen randomized trials involving 157,278 participants and 15,815 events contributed to the primary endpoint-harmonized analysis. Active therapy was associated with a lower risk of MACE than control (HR 0.84, 95% CI 0.79–0.88; I²=51%). In the sensitivity analysis restricted to strict 3-point MACE, 10 trials involving 98,973 participants and 9,067 events yielded a consistent pooled estimate with no observed heterogeneity (HR 0.83, 95% CI 0.80–0.86; I²=0%). Directionally consistent benefit was observed for sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and anti-inflammatory therapies. Estimates for proprotein convertase subtilisin/kexin type 9 inhibitors and omega-3 fatty acid-based therapies were based on limited trials and should be interpreted cautiously. No statistically significant effect modification by therapeutic class was detected, although the analysis was not designed to establish comparative equivalence across classes. Across randomized trials, contemporary cardiometabolic and anti-inflammatory therapies were associated with lower major adverse cardiovascular event risk. The consistency of findings in the strict 3-point MACE sensitivity analysis supports the robustness of the overall association. However, differences in heterogeneity and precision across therapeutic classes suggest that these therapies should not be assumed to be clinically interchangeable.

  • Open Access

    Feasibility of multidomain cardiovascular–kidney–metabolic biomarker assessment for in-hospital mortality in older heart failure inpatients: an exploratory retrospective cohort study

    by Musa Bin Bashir, Chen Chen, Ho Yong Il, Rzgar Mustafa Ahmed, Navneet Navneet, Zhiquan Wang

    Cardiovascular-kidney-metabolic (CKM) dysfunction integrates cardiac, renal, metabolic, and inflammatory risk and is particularly relevant for older patien

  • Open Access

    Comparative efficacy and safety of IL-17 and IL-23 inhibitors for moderate-to-severe psoriasis in Asian populations: a systematic review and meta-analysis

    by Mohammad Alzghool, Song Jiquan, Musa Bin Bashir

    Psoriasis is a chronic inflammatory skin disorder affecting a significant portion of the global population. Biologics targeting the IL-17 and IL-23 pathway


  • Assessment of medical students’ knowledge regarding radiation associated risk and its protection: finding from a cross-sectional study

    by Pardis Bahadori, Ana P. Molina-Recalde, Abdullah Saleh Alruwaili, Ahmed Alanazy, Wondimagegn Tibebu Tilahun, Gulsanga Ayub, Zia Ul Haq, Musa Bin Bashir

    Objective The current study assessed the knowledge of the medical students regarding the nature of radiation, associated risks, and protective measures. Method A cross-sectional study was conducted among international students enrolled in different medical colleges/universities in Xian, PR China. A self-developed and self-reported questionnaire was used for the current study. The descriptive statistics was carried out to summarize the finding of the study. Chi-square and Fisher exact tests were conducted to assess the association of the demographics with knowledge level. Results A total of 796 students responded among 980. Most of the participants fell in the age range of 20–25 years (42.6%), being male (67.1%) and having bachelor’s education (56.7%). Participants with previous experience was 58.7%. The age group of 20–25 years (p < 0.001), being male (p < 0.001), having bachelor education (p < 0.001), and previous experience (p = 0.009) was significantly associated with moderate to good knowledge. The overall knowledge about the nature of radiation (96%) and associated risk (82%) was good, but regarding protection, 59% of the participants showed good knowledge. Conclusion Most of the participants showed satisfactory result. However, the knowledge regarding protection measures was poor in almost half of the population.


  • Open Access

    Measuring the knowledge, attitude, and practice of self-measurement of blood pressure among cardiovascular patients in Pakistan

    by Musa Bin Bashir, Saba Ijaz, Muhammad Saeed, Famood Ali, Chenikala Srinivaslu

    Introduction: Self-measurement of blood pressure (SMBP) is a recent technique, already studied and validated, but it is still underused in the management of hypertension. The objective of the study was to evaluate the practice of SMBP in patients in management of hypertensive patients in Pakistan. Materials and methods: We conducted a descriptive prospective study during six months at the Institute of Cardiology of Pakistan Islamabad. Our study included patients aged at least 18 years old who were diagnosed with hypertension for at least six months and followed up in outpatient clinics. The analysis and processing of data were performed by SPSS software version 22. Results: Our study population was consisted of 300 patients with a male predominance (sex ratio of 1.46). The mean age of the patients was 41-60 years of age group. Our study showed that 39.6% of patients said they knew about blood pressure self-measurement before the therapeutic education; however, only 23.4% had already performed it. Medical staff talked to the patient about self-monitoring in 60% and encouraged the patient to perform SMBP. Conclusions: The practice of SMBP was low. However, when properly practiced, it reduced the occurrence of cardiovascular complications. The practice medical staff talked to the patient about self-monitoring have positive effects on patients’ SMBP.